IL295572A - Methods of preparing chiral benzodiazepinone derivatives - Google Patents
Methods of preparing chiral benzodiazepinone derivativesInfo
- Publication number
- IL295572A IL295572A IL295572A IL29557222A IL295572A IL 295572 A IL295572 A IL 295572A IL 295572 A IL295572 A IL 295572A IL 29557222 A IL29557222 A IL 29557222A IL 295572 A IL295572 A IL 295572A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- formula
- solvent
- combination
- represented
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/30—Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062977316P | 2020-02-16 | 2020-02-16 | |
| PCT/US2021/018137 WO2021163676A1 (en) | 2020-02-16 | 2021-02-16 | Methods of preparing chiral benzodiazepinone derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL295572A true IL295572A (en) | 2022-10-01 |
Family
ID=77291712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL295572A IL295572A (en) | 2020-02-16 | 2021-02-16 | Methods of preparing chiral benzodiazepinone derivatives |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12503449B2 (https=) |
| EP (1) | EP4107148A4 (https=) |
| JP (1) | JP2023513731A (https=) |
| KR (1) | KR20220143094A (https=) |
| CN (1) | CN115103836A (https=) |
| AU (1) | AU2021218456A1 (https=) |
| BR (1) | BR112022016249A2 (https=) |
| CA (1) | CA3171651A1 (https=) |
| IL (1) | IL295572A (https=) |
| MX (1) | MX2022010079A (https=) |
| WO (1) | WO2021163676A1 (https=) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0253571B1 (en) * | 1986-07-14 | 1989-08-23 | Merck & Co. Inc. | Process for resolution and race mization of amines with acidic alpha-hydrogens |
| NL9000386A (nl) * | 1990-02-16 | 1991-09-16 | Stamicarbon | Werkwijze voor de bereiding van optisch aktief aminozuuramide. |
| JPH0751555B2 (ja) | 1992-04-15 | 1995-06-05 | キヤノン株式会社 | ジイモニウム塩化合物 |
| BRPI0520554A2 (pt) * | 2005-09-19 | 2009-06-13 | Arrow Therapeutics Ltd | uso de uma benzodiazepina ou um sal farmaceuticamente aceitável do mesmo, método para tratar ou prevenir uma infecção por hcv em um paciente, derivado de benzodiazepina ou um sal famaceuticamente aceitável do mesmo, e, composição farmacêutica |
| WO2010073253A1 (en) | 2008-12-22 | 2010-07-01 | Natco Pharma Limited | Method for preparing an optically active frovatriptan |
| WO2013148554A1 (en) * | 2012-03-30 | 2013-10-03 | Merck Sharp & Dohme Corp. | Process for preparing fluoroleucine alkyl esters |
| CN105308030A (zh) * | 2012-09-21 | 2016-02-03 | 百时美施贵宝公司 | 烷基、氟烷基-1,4-苯并二氮杂*酮化合物 |
| EP2897942B1 (en) | 2012-09-21 | 2016-08-31 | Bristol-Myers Squibb Company | Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds as notch inhibitors |
| WO2014047392A1 (en) | 2012-09-21 | 2014-03-27 | Bristol-Myers Squibb Company | Fluoroalkyl-1,4-benzodiazepinone compounds |
| TWI614238B (zh) * | 2012-09-21 | 2018-02-11 | 必治妥美雅史谷比公司 | 雙（氟烷基）－１，４－苯并二氮呯酮化合物及其前藥 |
| JP6687596B2 (ja) | 2015-02-17 | 2020-04-22 | アモーレパシフィック コーポレーションＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ | Ｎ−［４−（１−アミノエチル）−フェニル］−スルホンアミド誘導体のキラル分割方法 |
| CN105439939B (zh) | 2015-11-12 | 2018-12-04 | 四川恒康科技发展有限公司 | 一种(S)-N-Boc-3-羟基哌啶的合成方法 |
-
2021
- 2021-02-16 CN CN202180014113.5A patent/CN115103836A/zh active Pending
- 2021-02-16 JP JP2022548818A patent/JP2023513731A/ja active Pending
- 2021-02-16 MX MX2022010079A patent/MX2022010079A/es unknown
- 2021-02-16 CA CA3171651A patent/CA3171651A1/en active Pending
- 2021-02-16 WO PCT/US2021/018137 patent/WO2021163676A1/en not_active Ceased
- 2021-02-16 IL IL295572A patent/IL295572A/en unknown
- 2021-02-16 BR BR112022016249A patent/BR112022016249A2/pt unknown
- 2021-02-16 KR KR1020227032186A patent/KR20220143094A/ko active Pending
- 2021-02-16 EP EP21753186.2A patent/EP4107148A4/en active Pending
- 2021-02-16 US US17/799,680 patent/US12503449B2/en active Active
- 2021-02-16 AU AU2021218456A patent/AU2021218456A1/en active Pending
-
2025
- 2025-07-24 US US19/279,615 patent/US20250346565A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN115103836A (zh) | 2022-09-23 |
| MX2022010079A (es) | 2022-09-02 |
| US20250346565A1 (en) | 2025-11-13 |
| BR112022016249A2 (pt) | 2022-10-11 |
| CA3171651A1 (en) | 2021-08-19 |
| EP4107148A1 (en) | 2022-12-28 |
| WO2021163676A1 (en) | 2021-08-19 |
| EP4107148A4 (en) | 2024-05-15 |
| US20230108536A1 (en) | 2023-04-06 |
| US12503449B2 (en) | 2025-12-23 |
| AU2021218456A1 (en) | 2022-09-22 |
| KR20220143094A (ko) | 2022-10-24 |
| JP2023513731A (ja) | 2023-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102482202B (zh) | 2-酰基氨基-3-联苯基丙酸的制备及拆分方法 | |
| IL311707A (en) | Methods for the separation of enantiomers | |
| RU2769445C2 (ru) | Новый способ и новые промежуточные соединения | |
| JP7138106B2 (ja) | 初期サクビトリル中間体のための新規な方法 | |
| IL262233A (en) | Meters a drug of consequence of amino acid | |
| IL284611B2 (en) | Chiral reagents for the preparation of homogeneous oligomers | |
| CN107250100B (zh) | 制备nep抑制剂的工艺和中间体 | |
| IL295572A (en) | Methods of preparing chiral benzodiazepinone derivatives | |
| CN116621742B (zh) | 氧代吡啶类化合物的新型制备方法及关键中间体 | |
| US8030486B2 (en) | Succinic acid diester derivative, process for production thereof, and use of the derivative in the production of pharmaceutical preparation | |
| JP5130212B2 (ja) | 光学活性３−アミノ−２，５−ジオキソピロリジン−３−カルボキシレート類およびその製造方法ならびに該化合物の使用 | |
| EA047658B1 (ru) | Способ синтеза липидов | |
| FI93547B (fi) | Menetelmä optisesti aktiivisten 2-alkyyli-2,5-diatsabisyklo/2,2,1/heptaanien valmistamiseksi | |
| Iwadate et al. | Synthesis of tetrahydro-β-carbolines via radical cyclization of 2-alkenylthioanilides | |
| EP1930321A1 (en) | Process for preparation of tetrasubstituted 5-azaspiro[2.4]- heptane derivatives and optically active intermediates thereof | |
| WO2024224426A1 (en) | Process for the preparation of 7-chloro-6-fluoro-(1m)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]pyrido[2,3-d] pyrimidine-2,4(1h,3h)-dione (m-dione) | |
| Matsuki et al. | ASYMMETRIC CONVERSION OF (Z)-N-BENZOYL-α-DEHYDRO (9-PHENANTHRYL) ALANINE N-METHYLAMIDE INTO ITS CYCLIZATION INTERMEDIATES VIA PHOTOINDUCED ELECTRON TRANSFER | |
| JP2023027698A (ja) | 光学活性ピロリジン誘導体またはその酸性塩、光学活性α－カルボリン誘導体、およびそれらの製造方法 | |
| IL323724A (en) | New compounds and their uses | |
| EA047685B1 (ru) | Способ синтеза катионных липидов | |
| IL298575A (en) | Methods for the synthesis of farnesyl dibenzodiazepinone | |
| JP2004131418A (ja) | ２−（Ｎ−ω−ヒドロキシアルキル）アミノメチル−１−置換ピロリジンの製造方法 | |
| JPWO2008081860A1 (ja) | 光学活性コハク酸イミド誘導体およびその製造方法ならびにその使用 |